<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The objective of this study was to evaluate the safety of using tegafur-<z:chebi fb="0" ids="17568">uracil</z:chebi> (UFT) in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients with partial dihydropyrimidine dehydrogenase (DPD) deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: The study included five <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients who presented with <z:hpo ids='HP_0011009'>acute</z:hpo> toxicity (grades 3 and 4) after being given the first cycle of chemotherapy using <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="C0268132" disease_type="Disease or Syndrome" abbrv="">DPD deficiency</z:e> was confirmed by gene sequencing </plain></SENT>
<SENT sid="3" pm="."><plain>After a full recovery from <z:hpo ids='HP_0000001'>all</z:hpo> side effects, we changed the regimen to UFT (300 mg/m(2)/day) associated with leucovorin (90 mg/day) for 21 days, with an empirical dose reduction of at least 10% in the first cycle </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We prospectively analysed 22 UFT cycles in 5 patients </plain></SENT>
<SENT sid="5" pm="."><plain>We did not observe any episodes of grade 3 or 4 toxicity </plain></SENT>
<SENT sid="6" pm="."><plain>The predominant toxicities were of grades 1 and 2 (<z:hpo ids='HP_0002018'>nausea</z:hpo>, <z:hpo ids='HP_0002013'>vomiting</z:hpo> and diarrhoea) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Here, we demonstrate a complete absence of severe toxicity in <z:hpo ids='HP_0000001'>all</z:hpo> patients and cycles analysed </plain></SENT>
<SENT sid="8" pm="."><plain>We believe that UFT is a safe alternative for the treatment of patients with partial <z:e sem="disease" ids="C0268132" disease_type="Disease or Syndrome" abbrv="">DPD deficiency</z:e> </plain></SENT>
</text></document>